As Vice President of US Clinical Operations at REV Clinical, Harakh Shah oversees global clinical trial execution, ensuring operational excellence, regulatory compliance, and on-time delivery across therapeutic areas including oncology, neurology, and ophthalmology.

With nearly 20 years of experience in pharmaceutical and CRO environments, Harakh has led large-scale global studies, managed complex portfolios, and driven audit and inspection readiness initiatives for agencies such as the FDA, EMA, and ANVISA.

He holds an M.Sc. in Clinical Research from Cranfield University, UK, and is a certified Project Management Institute (PMI) Professional. Recognized for his transparent, sponsor-focused leadership, Harakh consistently advances quality, accountability, and scientific rigor in every project.